tiprankstipranks
Intellia Therapeutics (NTLA)
NASDAQ:NTLA
NTLA
Intellia Therapeutics
RESEARCH TOOLSreports
Want to see NTLA full AI Analyst Report?

Intellia Therapeutics (NTLA) Revenue

4,923 Followers
StatisticsMarket CapRevenue

Intellia Therapeutics Revenue

Intellia Therapeutics had a revenue of 7.66M in the quarter ending Jun 30, 2026, with -49.10%. This bring the company's revenue in the last twelve months to 59.51M, Increased -9.96%. In the fiscal year ending Dec 31, 2025, Intellia Therapeutics had annual revenue of 67.67M with 16.92% growth.
Revenue (ttm)
59.51M
Revenue Growth
12.58%
P/S Ratio
24.70
Revenue/Employee
$179,499
Employees
377
Market Cap
$1.67B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
67.67M9.79M+16.92%
Dec 31, 2024
57.88M21.60M+59.55%
Dec 31, 2023
36.27M-15.85M-30.40%
Dec 31, 2022
52.12M19.07M+57.69%
Dec 31, 2021
33.05M-24.94M-43.01%
Dec 31, 2020
57.99M14.89M+34.55%
Dec 31, 2019
43.10M12.67M+41.63%
Dec 31, 2018
30.43M4.32M+16.53%
Dec 31, 2017
26.12M――